Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Ex Input:
Authorities have managed to mitigate the spread of the virus and the COVID-19 respiratory disease it causes among Singapore's citizens by rigorous contact tracing and surveillance, earning praise from the World Health Organization. The Ministry of Health reported just 14 cases among Singaporeans and permanent residents on Saturday. But the disease is spreading rapidly within the large migrant worker community, highlighting what rights groups say is a weak link in containment efforts. Authorities have ramped up testing for the disease in the dormitories. Saturday's new cases takes the total in the city-state, which is under a partial lockdown, to 5,992. It has reported 11 deaths from the disease.

Ex Output:
Singapore reports 942 new COVID-19 cases in record daily jump.

Ex Input:
Since Nov. 1, South Carolina has recorded 86 reported cases of the contagious disease. State Epidemiologist Linda Bell said Monday that's more than four times what state officials normally expect to see. Over the last 10 years, South Carolina averaged 19 reported cases of hepatitis A annually. Most of the new cases have occurred in Aiken County, and almost half of all cases involve individuals who reported drug use, Bell said. Still, the general population needn't be overly concerned, she said. "But we are seeing cases higher that what we expect to see," Bell said. "And so it's important for us to do our prevention efforts early to reach those high-risk groups, get them vaccinated ... so that we can prevent" a severe outbreak. The State reports the Department of Health and Environmental Control is offering no-cost vaccines to high risk groups including drug users, homeless, formerly incarcerated and sexually-active gay men. Additionally, health officials recommend all children get two doses of the vaccine as part of their immunization schedule. Of the 86 reported cases in South Carolina, 59 have led to hospitalization and one resulted in death, the DHEC said. Hepatitis is a disease characterized by inflammation of the liver. It comes in many forms, including hepatitis A, B and C. As a result, individuals with chronic liver disease, like cirrhosis, are at increased risk of complications if infected and should be vaccinated. The virus-borne infection can be prevented by vaccination and is usually transmitted person-to-person through consumption of contaminated food or water, according to the U.S. Centers for Disease Control and Prevention. Antibodies produced in response to hepatitis A infection last for life and protect against reinfection. Infection usually results in sickness in two to six weeks after exposure. Symptoms include fatigue, loss of appetite, stomach pain, nausea, and yellowing of the eyes and skin. Symptoms usually resolve within two months of infection, according to the CDC. State public health officials in February declared an outbreak in Aiken County after an employee at a second restaurant in Aiken tested positive for the virus, the DHEC said. Bell, though, stressed transmission by food or beverage is uncommon. "Most transmission in the United States is through person-to-person contact," Bell said. "Good hygiene - diligently washing your hands - is a good way to prevent hepatitis A, as well as not sharing personal items," including drug equipment, she said, adding the state has received reports of hepatitis A from people using various drugs, "everything from marijuana to meth." Residents can schedule an appointment for a vaccination at their local health department by calling 855-472-3432 or going to http://bit.ly/2HhEsM8 . ___ Information from: The State, http://www.thestate.com

Ex Output:
South Carolina declares hepatitis outbreak.

Ex Input:
The cost differences between aspirin and anticoagulant drugs are listed and the potential savings by using aspirin are highlighted. The release lists the percentages of patients who had a blood clot within three months of their knee replacement and emphasized that there was no statistical difference between those who took only aspirin and those who took anticoagulants. However, the release is remiss in notpointing out that the majority of patients were also treated with pneumatic compression boots. "Good old aspirin" implies that aspirin is benign and without potential harms, which is not accurate, even if the harms of aspirin are typically less than those of anticoagulants. There are two potential harms that were examined: bleeding and formation of clot. While the report notes that aspirin was "not inferior" to other anticoagulants, it was silent on the incidence of bleeding. In several places, the release mischaracterizes the study design and muddles distinctions between the results of this study and information from other sources. It neglects to point out key limitations noted by the study authors, including that the results seen in this network of Michigan hospitals may not reflect the experiences of patients elsewhere and that "this is an observational study and can only demonstrate association and not causation." The study variable was the choice of a clot-prevention drug prescribed to patients the day before surgery, the day of surgery and the day after. The release muddles things by stating, "it's routine for patients to take clot-preventing drugs for some time afterward." The headline, subhead and lead sentence all refer to patients taking aspirin "after" or "following" a knee replacement. Readers are likely to mistakenly believe that the study looked at long-term use of clot-preventing drugs, rather than what it actually tracked: the choice of drug for the brief 3-day period around the procedure. The release also quotes a researcher saying, "This study is truly a real-world experience of what happened in Michigan when the majority of surgeons switched to aspirin," Hallstrom says. "The incidence of blood clots, pulmonary embolus and death did not increase despite this dramatic change in practice." However, this study was not set up to compare outcomes before and after a change in practice, so this prominent description of the study is not faithful to the actual study design. The release refers to "the two-year study period," which readers could misinterpret to mean patients were followed for two-years, not just 90 days; though elsewhere the release does refer to the percentage of blood clots "over three months." The release does not push knee replacement or clot-preventing drugs, though it does somewhat overstate the number of total knee replacements. The release cites a figure of "nearly 1 million Americans" each year, while other sources estimate the rate is closer to 700,000 per year. The disclosure statements included with the journal article reporting on this study note that Blue Cross and Blue Shield of Michigan support the quality improvement group that did this study and pay some of the salaries of key researchers. Even though the disclosure statements say Blue Cross and Blue Shield did not specifically fund the work on this study, the release should have noted the funding relationship. The release highlights the comparison between alternatives for minimizing blood clot risk due to knee replacement surgery. The release notes that many knee replacements surgeries are performed every year. The release notes that the question of the best clot-prevention strategy for knee replacement patients has been debated for years. It cites an advantage over one recent study. Comparing the language of the release to the more-specific description in the journal article, it does seem that the release appropriately portrays this study as adding to the evidence that surgeons can use when prescribing drugs. Although the release paints a rather rosy and benign image of "good old aspirin," the release is clear that this study found that there was no statistical difference in outcomes between patients taking aspirin versus anticoagulant drugsand it pointed out that doctors need to consider a patient's history of blood clots, obesity and other factors.

Ex Output:
Aspirin alone a good clot buster after knee surgery